Reversal of severe biventricular dysfunction from cardiac hemochromatosis with Iron removal

Circulation: Heart Failure

Volumn 6, Issue 1, 2013, Pages

  Chow, Chen H ^a   El Amm, Chantal ^a   Liu, Wendy ^a,b   Pastva, Stephen ^a,b,c   Sipahi, Ilke ^a   Fang, James C ^a,b,c  

^a Division of Cardiovascular Medicine   (United States)

^b Harrington Heart and Vascular Institute   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DIGOXIN; FERRITIN; SPIRONOLACTONE; TORASEMIDE;

ADULT; CASE REPORT; COUGHING; DISEASE DURATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FERRITIN BLOOD LEVEL; HEART LEFT ANTERIOR BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE FUNCTION; HEMOCHROMATOSIS; HUMAN; HYPOTENSION; MALE; NOTE; PHLEBOTOMY; PRIORITY JOURNAL; PROGNOSIS; SWELLING; SYSTEMIC VASCULAR RESISTANCE;

BIOPSY; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; HEART DISEASES; HEMOCHROMATOSIS; HUMANS; IRON; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SORPTION DETOXIFICATION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION;

EID: 84873696446     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.971747     Document Type: Note

References (3)

1. Olson LJ, Baldus WP, Tajik AJ. Echocardiographic features of idiopathic hemochromatosis. Am J Cardiol. 1987;60:885-889.
2. Mcallen PM, Coghill NF, Lubran M. The treatment of haemochromatosis with particular reference to the removal of iron from the body by repeated venesection. Q J Med. 1957;26:251-276.
3. Phatak P, Brissot P, Wurster M, Adams PC, Bonkovsky HL, Gross J, Malfertheiner P, McLaren GD, Niederau C, Piperno A, Powell LW, Russo MW, Stoelzel U, Stremmel W, Griffel L, Lynch N, Zhang Y, Pietrangelo A. A phase , dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology. 2010;52:1671-1779.